Electric Frontiers: Innovations in Cardiac Electrophysiology and Arrhythmia Management


Authors : Amulya Yellamilli; Bhuvaneswari Kalijavedu Ravi; Deexitha Mudigonda; Nabilah Subahani; Hrithik Chandhar; Zahra

Volume/Issue : Volume 10 - 2025, Issue 7 - July


Google Scholar : https://tinyurl.com/2dr5zn7a

Scribd : https://tinyurl.com/4kmtw4tw

DOI : https://doi.org/10.38124/ijisrt/25jul1889

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.


Abstract : Arrhythmias remain a major hurdle to healthcare systems, especially atrial fibrillation (AF) and ventricular tachyarrhythmias as they pose significant risk for stroke and sudden cardiac death (SCD). Post-MI scars pose a risk for ventricular tachycardias (VTs) development due to re-entry of electric signals back into the scar tissue. Recent advancements in the field of cardiac electrophysiology enables detection and management of arrhythmias. Novel risk stratification methods such as ABC-stroke score have demonstrated higher accuracy in predicting risk of stroke in AF. Amulet implants have been recently approved as an alternative for oral anticoagulants. Innovations like pulsed field ablation (PFA) have provided a safer, tissue selective approach in managing arrhythmias. Implantable Cardioverter‐Defibrillators (ICDs) along with catheter ablation (CA) techniques marked to be practical therapy for recurrent VT. Artificial Intelligence (AI) powered algorithms are utilized for interpretation of electrocardiograms (ECGs), which is more sensitive and accurate. Remote monitoring (RM) is a cornerstone for modern arrhythmia management. It includes smartwatches, patch-based ECG monitoring, and implantable loop recorders. This enables for real time monitoring, aids in early diagnosing and intervention. Robotic magnetic guided navigation during CA can overcome complex procedural complications and treat arrhythmias. Clinical trials in gene therapy show promising results in offering new scope of managing arrhythmias. This review highlights the recent innovations in detecting and managing cardiac arrhythmias, marking a shift towards more of a technological driven approach.

Keywords : Cardiac Arrhythmias; Atrial Fibrillation; Implantable Loop Devices; Pulsed Field Ablation; Ventricular Arrhythmias; AI- Enhanced Ecgs; Wearable Devices.

References :

  1. Nagpal AK, Pundkar A, Singh A, Gadkari C. Cardiac Arrhythmias and their Management: An In-Depth Review of current practices and emerging therapies. Cureus. 2024. https://doi.org/10.7759/cureus.66549
  2. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2020;16(2):217–221. https://doi.org/10.1177/1747493019897870
  3. Kornej J, Börschel CS, Benjamin EJ, Schnabel RB. Epidemiology of Atrial fibrillation in the 21st century. Circ Res. 2020;127(1):4–20. https://doi.org/10.1161/circresaha.120.316340
  4. Cheng S, He J, Han Y, Han S, Li P, Liao H, et al. Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2021. EP Europace. 2024;26(7). https://doi.org/10.1093/europace/euae195
  5. Järvensivu-Koivunen M, Tynkkynen J, Oksala N, Eskola M, Hernesniemi J. Ventricular arrhythmias and haemodynamic collapse during acute coronary syndrome: increased risk for sudden cardiac death? Eur J Prev Cardiol. 2024;31(18):2117–2124. https://doi.org/10.1093/eurjpc/zwae074
  6. Srinivasan NT, Schilling RJ. Sudden cardiac death and arrhythmias. Arrhythm Electrophysiol Rev. 2018;7(2):111. https://doi.org/10.15420/aer.2018:15:2
  7. Bokhari SFH, Waseem AB, Raza H, Iqbal A, Javaid S, Idrees B, et al. Advancing cardiac arrhythmia management: The integration of wearable technology and remote monitoring. World J Cardiol. 2025;17(7). https://doi.org/10.4330/wjc.v17.i7.106841
  8. Lubitz SA, Faranesh AZ, Selvaggi C, Atlas SJ, McManus DD, Singer DE, et al. Detection of atrial fibrillation in a large population using wearable devices: the Fitbit Heart Study. Circulation. 2022;146(19):1415–1424. https://doi.org/10.1161/circulationaha.122.060291
  9. Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol. 2019;74(3):315–326. https://doi.org/10.1016/j.jacc.2019.04.021
  10. Attia ZI, Noseworthy PA, Lopez-Jimenez F, Asirvatham SJ, Deshmukh AJ, Gersh BJ, et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet. 2019;394(10201):861–867. https://doi.org/10.1016/S0140-6736(19)31721-0
  11. Fu D. Cardiac arrhythmias: diagnosis, symptoms, and treatments. Cell Biochem Biophys. 2015;73(2):291–296. https://doi.org/10.1007/s12013-015-0626-4
  12. Babu M, Lautman Z, Lin X, Sobota MH, Snyder MP. Wearable Devices: Implications for precision medicine and the future of health care. Annu Rev Med. 2023;75(1):401–415. https://doi.org/10.1146/annurev-med-052422-020437
  13. Nagarajan VD, Lee S, Robertus J, Nienaber CA, Trayanova NA, Ernst S. Artificial intelligence in the diagnosis and management of arrhythmias. Eur Heart J. 2021;42(38):3904–3916. https://doi.org/10.1093/eurheartj/ehab544
  14. Shade JK, Ali RL, Basile D, Popescu D, Akhtar T, Marine JE, et al. Preprocedure Application of Machine Learning and Mechanistic Simulations Predicts Likelihood of Paroxysmal Atrial Fibrillation Recurrence Following Pulmonary Vein Isolation. Circ Arrhythm Electrophysiol. 2020;13(7):e008213. https://doi.org/10.1161/CIRCEP.119.008213
  15. Bisignani A, De Bonis S, Mancuso L, Ceravolo G, Bisignani G. Implantable loop recorder in clinical practice. J Arrhythm. 2018;35(1):25–32. https://doi.org/10.1002/joa3.12142
  16. Bauer BK, Meier C, Bietenbeck M, Lange PS, Eckardt L, Yilmaz A. Cardiovascular Magnetic Resonance-Guided radiofrequency ablation. JACC Clin Electrophysiol. 2022;8(2):261–274. https://doi.org/10.1016/j.jacep.2021.11.017
  17. Kuwahara T. Intracardiac Echocardiography in Catheter Ablation for Atrial Fibrillation: It Is Better to See What You Are Doing? J Atrial Fibrillation. 2015;7(6):1215. https://doi.org/10.4022/jafib.1215
  18. Bazoukis G, Elkholey K, Stavrakis S, Heist EK, Armoundas AA. Efficacy of commonly used 3D mapping systems in acute success rates of catheter ablation procedures. Heart Int. 2024;18(1). https://doi.org/10.17925/hi.2024.18.1.3
  19. Lakkireddy D, Thaler D, Ellis CR, Swarup V, Sondergaard L, Carroll J, et al. Amplatzer Amulet Left Atrial Appendage Occluder versus Watchman Device for Stroke Prophylaxis (Amulet IDE): a randomized, controlled trial. Circulation. 2021;144(19):1543–1552. https://doi.org/10.1161/circulationaha.121.057063
  20. Na J, Garapati SS, Lador A. Obesity and Atrial  Fibrillation: A Comprehensive review. Methodist   Debakey Cardiovasc J. 2025;21(2):35–43. https://doi.org/10.14797/mdcvj.1516
  21. Ardissino M, Reddy RK, Slob EAW, Patel KHK, Ryan DK, Gill D, et al. Sleep disordered breathing, obesity and atrial fibrillation: a Mendelian randomisation study. Genes. 2022;13(1):104. https://doi.org/10.3390/genes13010104
  22. Edpuganti S, Thomas KS, Ponnuri SSA, Tomar RK, Kapuge PH. Obesity and metabolic syndrome: Pathophysiological mechanisms driving cardiovascular risk. Junior Researchers. 2025;3(3):20–35. https://doi.org/10.52340/jr.2025.03.03.03
  23. Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2023;149(1). https://doi.org/10.1161/cir.0000000000001193
  24. Xing LY, Diederichsen SZ, Højberg S, Krieger DW, Graff C, Frikke‐Schmidt R, et al. The ABC‐Stroke Risk Score and Effects of Atrial fibrillation screening on stroke prevention: results from the randomized LOOP study. J Am Heart Assoc. 2024;13(4). https://doi.org/10.1161/jaha.123.032744
  25. Frazzetto M, Sanfilippo C, Costa G, Contrafatto C, Giacalone C, Scandura S, et al. Watchman vs. Amulet for Left Atrial Appendage Closure: Current Evidence and Future Perspectives. J Clin Med. 2024;13(16):4651. https://doi.org/10.3390/jcm13164651
  26. Kowalewski M, Dąbrowski EJ, Kurasz A, Święczkowski M, Raffa GM, Kawczyński M, et al. Surgical ablation of atrial fibrillation with concomitant cardiac surgery. A state-of-the-art review. Eur J Cardiothorac Surg. 2025. https://doi.org/10.1093/ejcts/ezaf187
  27. Jensen M, Suling A, Metzner A, Schnabel RB, Borof K, Goette A, et al. Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial. Lancet Neurol. 2022;22(1):45–54. https://doi.org/10.1016/s1474-4422(22)00436-7
  28. Willems S, Borof K, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, et al. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial. Eur Heart J. 2021;43(12):1219–1230. https://doi.org/10.1093/eurheartj/ehab593
  29. Zhu W, Wu Z, Dong Y, Lip GYH, Liu C. Effectiveness of early rhythm control in improving clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis. BMC Med. 2022;20(1). https://doi.org/10.1186/s12916-022-02545-4
  30. Mililis P, Kariki O, Saplaouras A, Bazoukis G, Dragasis S, Patsiotis IG, et al. Radiofrequency versus cryoballoon catheter ablation in patients with persistent atrial fibrillation: A randomized trial. J Cardiovasc Electrophysiol. 2023;34(7):1523–1528. https://doi.org/10.1111/jce.15965
  31. Lo M, Gambhir A, Sundaram S, Sanders P, DeLurgio D, Trivedi A, et al. Safety and effectiveness of a novel Balloon-in-Basket pulsed Field ablation catheter for the treatment of paroxysmal and persistent AF: VOLT-AF IDE Trial acute results. Heart Rhythm. 2025. https://doi.org/10.1016/j.hrthm.2025.04.037
  32. Reddy VY, Calkins H, Mansour M, Wazni O, Di Biase L, Bahu M, et al. Pulsed field ablation to treat paroxysmal atrial fibrillation: Safety and effectiveness in the ADMIRE pivotal trial. Circulation. 2024;150(15):1174–1186. https://doi.org/10.1161/circulationaha.124.070333
  33. Reddy VY, Gerstenfeld EP, Schmidt B, Andrade JG, Nair D, Natale A, et al. Pulsed field ablation of persistent atrial fibrillation with continuous ECG monitoring Follow-Up: ADVANTAGE AF-Phase 2. Circulation. 2025. https://doi.org/10.1161/circulationaha.125.074485
  34. Van Der Heijden CAJ, Aerts L, Chaldoupi S, Van Cruchten C, Kawczynski M, Heuts S, et al. Hybrid atrial fibrillation ablation. Ann Cardiothorac Surg. 2024;13(1):54–70. https://doi.org/10.21037/acs-2023-afm-0129
  35. Zeppenfeld K, Tfelt-Hansen J, De Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997–4126. https://doi.org/10.1093/eurheartj/ehac262
  36. Suryanarayana P, Garza HK, Klewer J, Hutchinson MD. Electrophysiologic considerations after sudden cardiac arrest. Curr Cardiol Rev. 2018;14(2):102–108. https://doi.org/10.2174/1573403x14666180507164443
  37. Ammar A, Sharief M, Abouelmagd K, Riad O, Ibrahim M. Outcomes of catheter ablation of ventricular tachycardia in non-ischemic idiopathic dilated cardiomyopathy: A systematic review and meta-analysis. Front Cardiovasc Med. 2022;9. https://doi.org/10.3389/fcvm.2022.1007392
  38. Da Silva GL, Cortez-Dias N, Carpinteiro L, Pinto FJ, De Sousa J. Outcome of ventricular tachycardia catheter ablation in ischemic heart disease patients using a high-density mapping substrate-based approach: A prospective cohort study. Rev Port Cardiol. 2022;41(4):325–335. https://doi.org/10.1016/j.repc.2021.02.026
  39. Oomen AWGJ, Dekker LRC, Meijer A. Catheter ablation of symptomatic idiopathic ventricular arrhythmias. Neth Heart J. 2018;26(4):210–216. https://doi.org/10.1007/s12471-018-1085-5
  40. Kim JA, Chelu MG. Inherited arrhythmia syndromes. Tex Heart Inst J. 2021;48(4). https://doi.org/10.14503/thij-20-7482
  41. Krahn AD, Wilde AA, Calkins H, La Gerche A, Cadrin-Tourigny J, Roberts JD, et al. Arrhythmogenic right ventricular cardiomyopathy. JACC Clin Electrophysiol. 2022;8(4):533–553. https://doi.org/10.1016/j.jacep.2021.12.002
  42. Kirkels FP, Van Osta N, Rootwelt-Norberg C, Chivulescu M, Van Loon T, Aabel EW, et al. Monitoring of myocardial involvement in early arrhythmogenic right ventricular cardiomyopathy across the age spectrum. J Am Coll Cardiol. 2023;82(9):785–797. https://doi.org/10.1016/j.jacc.2023.05.065
  43. Edpuganti S. Fungal endocarditis: Microbial insights, diagnostic and therapeutic challenges in the modern era. Explor Cardiol. 2025;3:101264. https://doi.org/10.37349/ec.2025.101264
  44. Vouliotis AI, Roberts PR, Dilaveris P, Gatzoulis K, Yue A, Tsioufis K. Leadless pacemakers: Current achievements and future perspectives. Eur Cardiol Rev. 2023;18. https://doi.org/10.15420/ecr.2022.32
  45. Oliveira VMR, Rivera A, Oliveira IC, De Sousa AM, Nishikubo MEP, Serpa F, et al. The effectiveness and safety of leadless pacemakers: An updated meta-analysis. Curr Cardiol Rep. 2024;26(8):789–799. https://doi.org/10.1007/s11886-024-02079-6
  46. Guarracini F, Preda A, Bonvicini E, Coser A, Martin M, Quintarelli S, et al. Subcutaneous implantable cardioverter defibrillator: A contemporary overview. Life. 2023;13(8):1652. https://doi.org/10.3390/life13081652
  47. Strocchi M, Lee AW, Neic A, Bouyssier J, Gillette K, Plank G, et al. His-bundle and left bundle pacing with optimized atrioventricular delay achieve superior electrical synchrony over endocardial and epicardial pacing in left bundle branch block patients. Heart Rhythm. 2020;17(11):1922–1929. https://doi.org/10.1016/j.hrthm.2020.06.028
  48. Herweg B, Sharma PS, Cano Ó, Ponnusamy SS, Zanon F, Jastrzebski M, et al. Arrhythmic risk in biventricular pacing compared with left bundle branch area pacing: results from the I-CLAS study. Circulation. 2023;149(5):379–390. https://doi.org/10.1161/circulationaha.123.067465
  49. Fortuni F, Casula M, Sanzo A, Angelini F, Cornara S, Somaschini A, et al. Meta-Analysis Comparing cryoballoon versus radiofrequency as first ablation procedure for atrial fibrillation. Am J Cardiol. 2020;125(8):1170–1179. https://doi.org/10.1016/j.amjcard.2020.01.016
  50. Moore OM, Ho KS, Copeland JS, Parthasarathy V, Wehrens XHT. Genome editing and cardiac arrhythmias. Cells. 2023;12(10):1363. https://doi.org/10.3390/cells12101363
  51. Karatela MF, Fudim M, Mathew JP, Piccini JP. Neuromodulation therapy for atrial fibrillation. Heart Rhythm. 2022;20(1):100–111. https://doi.org/10.1016/j.hrthm.2022.08.011
  52. Nawar K, Mohammad A, Johns EJ, Abdulla MH. Renal denervation for atrial fibrillation: a comprehensive updated systematic review and meta-analysis. J Hum Hypertens. 2022;36(10):887–897. https://doi.org/10.1038/s41371-022-00658-0
  53. Steinberg JS, Shabanov V, Ponomarev D, Losik D, Ivanickiy E, Kropotkin E, et al. Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension. JAMA. 2020;323(3):248. https://doi.org/10.1001/jama.2019.21187
  54. Trayanova NA, Pashakhanloo F, Wu KC, Halperin HR. Imaging-based simulations for predicting sudden death and guiding ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2017;10(7). https://doi.org/10.1161/circep.117.004743
  55. Cernica D, Benedek I, Polexa S, Tolescu C, Benedek T. 3D printing—A cutting edge technology for treating post-infarction patients. Life. 2021;11(9):910. https://doi.org/10.3390/life11090910
  56. Wang D, Veltmann C, Bauersachs J, Duncker D. Antiarrhythmic effects of baroreceptor activation therapy in chronic heart failure: a case report. Eur Heart J Case Rep. 2023;7(11). https://doi.org/10.1093/ehjcr/ytad520
  57. Robles-Mezcua A, Villaescusa-Catalán JM, Melero-Tejedor JM, García-Pinilla JM. A new approach to the treatment of advanced heart failure: a case report. Eur Heart J Case Rep. 2021;5(2). https://doi.org/10.1093/ehjcr/ytaa541
  58. Abdelrazik A, Eldesouky M, Antoun I, Lau EYM, Koya A, Vali Z, et al. Wearable devices for arrhythmia detection: advancements and clinical implications. Sensors. 2025;25(9):2848. https://doi.org/10.3390/s25092848
  59. Bogár B, Pető D, Sipos D, Füredi G, Keszthelyi A, Betlehem J, Pandur AA. Detection of arrhythmias using smartwatches—A systematic literature review. Healthcare. 2024;12(9):892. https://doi.org/10.3390/healthcare12090892
  60. Preda A, Falco R, Tognola C, Carbonaro M, Vargiu S, Gallazzi M, et al. Contemporary advances in cardiac remote monitoring: a comprehensive, updated mini-review. Medicina. 2024;60(5):819. https://doi.org/10.3390/medicina60050819
  61. Goudarzi MTH, Marzouni HZ, Tarkhan F, Bijani A, Babagoli M, Shadifar A, Alipour JA. A new remote monitoring system: evaluation of the efficiency and accuracy of the Smart Emergency Medical System-Health Internet of Things device. Galen Med J. 2024;13:e3376. https://doi.org/10.31661/gmj.v13i.3376
  62. Jena N, Singh P, Chandramohan D, Garapati HN, Gummadi J, Mylavarapu M, et al. Wearable technology in cardiology: advancements, applications, and future prospects. Rev Cardiovasc Med. 2025;26(6). https://doi.org/10.31083/rcm39025
  63. Wang J, Verkerk AO, Wilders R, Zhang Y, Zhang K, Prakosa A, et al. SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias. Eur Heart J. 2025. https://doi.org/10.1093/eurheartj/ehaf053
  64. Park E, Kim J, Seong E, Lee E, Chang K, Choi Y. Effects of mesenchymal stem cell injection into healed myocardial infarction scar border zone on the risk of ventricular tachycardia. Biomedicines. 2023;11(8):2141. https://doi.org/10.3390/biomedicines11082141
  65. Khairy P, Dyrda K, Mondésert B, Aguilar M, Dubuc M, Cadrin-Tourigny J, et al. Overcoming access challenges to treat arrhythmias in patients with congenital heart disease using robotic magnetic-guided catheter ablation. J Clin Med. 2024;13(18):5432. https://doi.org/10.3390/jcm13185432
  66. Ijaz R, Singh A, Qazi M, Kachhadia M, Qayoom L, Riaz S, et al. Comparison between efficacy and safety of remote magnetic navigation and manual catheter navigation for atrial fibrillation ablation: an updated meta-analysis and systematic review. J Innov Cardiac Rhythm Manage. 2025;16(6):6307–6328. https://doi.org/10.19102/icrm.2025.16065

Arrhythmias remain a major hurdle to healthcare systems, especially atrial fibrillation (AF) and ventricular tachyarrhythmias as they pose significant risk for stroke and sudden cardiac death (SCD). Post-MI scars pose a risk for ventricular tachycardias (VTs) development due to re-entry of electric signals back into the scar tissue. Recent advancements in the field of cardiac electrophysiology enables detection and management of arrhythmias. Novel risk stratification methods such as ABC-stroke score have demonstrated higher accuracy in predicting risk of stroke in AF. Amulet implants have been recently approved as an alternative for oral anticoagulants. Innovations like pulsed field ablation (PFA) have provided a safer, tissue selective approach in managing arrhythmias. Implantable Cardioverter‐Defibrillators (ICDs) along with catheter ablation (CA) techniques marked to be practical therapy for recurrent VT. Artificial Intelligence (AI) powered algorithms are utilized for interpretation of electrocardiograms (ECGs), which is more sensitive and accurate. Remote monitoring (RM) is a cornerstone for modern arrhythmia management. It includes smartwatches, patch-based ECG monitoring, and implantable loop recorders. This enables for real time monitoring, aids in early diagnosing and intervention. Robotic magnetic guided navigation during CA can overcome complex procedural complications and treat arrhythmias. Clinical trials in gene therapy show promising results in offering new scope of managing arrhythmias. This review highlights the recent innovations in detecting and managing cardiac arrhythmias, marking a shift towards more of a technological driven approach.

Keywords : Cardiac Arrhythmias; Atrial Fibrillation; Implantable Loop Devices; Pulsed Field Ablation; Ventricular Arrhythmias; AI- Enhanced Ecgs; Wearable Devices.

CALL FOR PAPERS


Paper Submission Last Date
31 - December - 2025

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe